Cliff Asness’s TScan Therapeutics TCRX Stock Holding History
Bought
Maintained
Sold
Other funds holding TCRX
LCM
BBA
DF
Cliff Asness's TCRX Position: Q3 2026 in Review
Cliff Asness opened a new position in TScan Therapeutics (TCRX) in Q3 2026: 13,866 shares worth $4.36K. The stake represents ﹤0.01% of the portfolio and ranks #4056 among its holdings. This is a return to the name: Cliff Asness previously reported a position in TCRX as recently as Q2 2025.
Cliff Asness first reported a position in TCRX in Q3 2024 and has held it in 3 quarters since. The position peaked at $64.3K in Q3 2024. 51 funds tracked by Wall St. Rank hold TCRX as of Q3 2026.
- Cliff Asness held 13,866 shares of TScan Therapeutics worth $4.36K as of Q3 2026.
- TScan Therapeutics was a new Cliff Asness position in Q3 2026.
- TScan Therapeutics made up ﹤0.01% of Cliff Asness's portfolio in Q3 2026, its #4056 holding.
- Cliff Asness first reported a position in TScan Therapeutics in Q3 2024 and has held it in 3 quarters since.
- Cliff Asness's TScan Therapeutics position peaked at $64.3K in Q3 2024.
- 51 funds tracked by Wall St. Rank held TScan Therapeutics as of Q3 2026.
Based on AQR Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.